News | 09 January 2013
K-V Pharmaceutical Co. Monday unveiled a bankruptcy-exit plan that hinges on a $20 million rights offering and has already earned the support of a group of senior noteholders. Read the Daily Bankruptcy Review article here. (Daily Bankruptcy Review and ...
Click on the link to read the full article at Wall Street Journal (blog)
(This link will open in a new window)